J&J Says It Plans to End Covid-19 Vaccine Supply Deal With Emergent BioSolutions

Johnson & Johnson said Monday it planned to terminate its Covid-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each other of breaching the agreement.

J&J informed Emergent last week of its plan to terminate the 2020 manufacturing agreement “based on Emergent’s breaches, including failure to supply Covid-19 vaccine drug substance,” J&J said in a written statement.

Source link

Leave a Reply

Your email address will not be published.